Asymmetric dimethylarginine (Synonyms: ADMA, Asymmetric dimethylarginine) |
رقم الكتالوجGC32457 |
ثنائي ميثيلارجينين غير المتماثل هو مثبط داخلي لأكسيد النيتريك سينثاز (NOS) ، ويعمل كعلامة على الخلل البطاني في عدد من الحالات المرضية
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 30315-93-6
Sample solution is provided at 25 µL, 10mM.
Asymmetric dimethylarginine is an endogenous inhibitor of nitric oxide synthase (NOS), and functions as a marker of endothelial dysfunction in a number of pathological states.
Asymmetric dimethylarginine is an endogenous inhibitor of nitric oxide synthase (NOS), and functions as a marker of endothelial dysfunction in a number of pathological states. Asymmetric dimethylarginine (ADMA) is elevated in HIV-1 infection[1].
[1]. Hudson CL, et al. The cardiovascular risk marker asymmetric dimethylarginine is elevated in asymptomatic, untreated HIV-1 infection and correlates with markers of immune activation and disease progression. Ann Clin Biochem. 2014 Sep;51(Pt 5):568-75.
Average Rating: 5
(Based on Reviews and 19 reference(s) in Google Scholar.)GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *